Wuwu Biotech: Announcement on the progress of matters involving the company in litigation
Wowu Biotech: Announcement on the joint company obtaining a clinical trial summary report for products under development
Zhejiang Wolwo Bio-Pharmaceutical: Summary of Non-operating Fund Occupancy and Other Related Fund Transactions (June 30, 2024)
Zhejiang Wolwo Bio-Pharmaceutical: Announcement on the Entry of the First Subject in Phase II Clinical Trial of Dermatitis Diagnostic Patch 01
Zhejiang Wolwo Bio-Pharmaceutical: Announcement Regarding Company-Related Litigation.
Zhejiang Wolwo Bio-Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Zhejiang Wolwo Bio-Pharmaceutical: Legal Opinion on the 2023 Annual General Meeting of Shareholders of Zhejiang Wuwu Biotechnology Co., Ltd.
Zhejiang Wolwo Bio-Pharmaceutical: Announcement on changes in the company's pharmaceutical production license
Wowu Biotech: Announcement on the progress of the “Double Improvement of Quality and Return” action plan
Wawu Biotech: 2023 Financial Results Report
Obu Biotech: Rules of Procedure for the Board of Directors (April 2024)
Wuwu Biotech: Notice on Convening the 2023 Annual General Meeting of Shareholders
Wawu Biotech: 2023 Internal Control Evaluation Report
Wuwu Biotech: Report on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties of accounting firms by the Board of Directors Audit Committee
Wawu Biotech: 2023 Annual Financial Report
Wowu Biotech: Announcement on the shareholder return plan for the next three years (2024-2026)
Wowu Biotech: Announcement on the “Double Improvement of Quality and Return” action plan
Obu Biotech: External Guarantee System (December 2023)
Wubu Biotech: Legal Opinion of the First Extraordinary General Meeting of Shareholders in 2023
Wuwu Biotech: Announcement of Resolutions of the First Extraordinary General Meeting of Shareholders in 2023
No Data
No Data